Elevated expressions of Hec1 have been observed in a wide range of human malignancies, and correlate with poorer clinical prognoses in cancers including brain, liver, breast, colon, stomach, and lung cancers (11, 16–18). This evidence concerns the gene NDC80 and cancer.